Literature DB >> 8682162

Induction of glutathione-S-transferase-pi by short-chain fatty acids in the intestinal cell line Caco-2.

J Stein1, O Schröder, M Bonk, G Oremek, M Lorenz, W F Caspary.   

Abstract

Glutathione S-transferases (GSTs) are a multigene family of detoxification and metabolizing enzymes that have been linked with the susceptibility of tissues to environmental carcinogens. In addition to their role as the main energy source in the colonic mucosa, short-chain fatty acids (SCFAs) have been found to act as potent antiproliferative and differentiating agents in various cancer cell lines. The objective of this study was to evaluate the effects of SCFAs on the induction of GSTpi in the intestine as a possible new anticarcinogenic mechanism of SCFAs. Studies were performed in Caco-2 cells, a cell line resembling functionally normal enterocytes. Cells, cultured in DMEM supplemented with 10% fetal calf serum, were studied from day 0 dpc (days post confluence) until 21 dpc and culture. SCFAs (acetate, propionate, butyrate) were added to give a final concentration of 5 mmol L(-1). At 0, 3, 6, 9, 15, and 21 dpc, protein, lactate dehydrogenase (LDH), alkaline phosphatase (AP) and GSTpi were measured. Butyrate supplementation significantly (P < or = 0.01) increased GSTpi levels compared with controls in a concentration-dependent manner. The effect was detectable within 3 dpc with a maximum at 15 dpc. In contrast to butyrate, the other SCFAs tested had no (acetate) or little effect (propionate). In conclusion, the data suggest that the anticancer effect of butyrate in part may be based on the induction of GSTpi activity, resulting in an enhanced detoxification capacity of the gut.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682162     DOI: 10.1046/j.1365-2362.1996.113252.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Growth inhibition and induction of differentiation and apoptosis mediated by sodium butyrate in Caco-2 cells with algal glycolipids.

Authors:  Zakir Hossain; Hideyuki Kurihara; Masashi Hosokawa; Koretaro Takahashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

2.  The gut fermentation product butyrate, a chemopreventive agent, suppresses glutathione S-transferase theta (hGSTT1) and cell growth more in human colon adenoma (LT97) than tumor (HT29) cells.

Authors:  Tanja Kautenburger; Gabriele Beyer-Sehlmeyer; Grit Festag; Natja Haag; Stephanie Kühler; Alma Küchler; Anja Weise; Brigitte Marian; Wilbert H M Peters; Thomas Liehr; Uwe Claussen; Beatrice L Pool-Zobel
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

Review 3.  Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer.

Authors:  Maya Raman; Padma Ambalam; Kanthi Kiran Kondepudi; Sheetal Pithva; Charmy Kothari; Arti T Patel; Ravi Kiran Purama; J M Dave; B R M Vyas
Journal:  Gut Microbes       Date:  2013-03-19

4.  RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice.

Authors:  Felcy Pavithra Selwyn; Julia Yue Cui; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2015-05-08       Impact factor: 3.922

Review 5.  Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer.

Authors:  Mridul Sharma; Geeta Shukla
Journal:  Front Microbiol       Date:  2016-12-02       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.